Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2022-09-16 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate loss and related disclosures. The content is about notifying the exchange of lost share certificates and does not contain financial data, management discussion, voting results, or any report publication. It is a regulatory compliance notification related to shareholding records but does not fit into categories like Major Shareholding Notification (MRQ) since it does not report changes in ownership levels, nor is it a Director's Dealing or Share Issue announcement. Given the nature and content, it best fits under Regulatory Filings (RNS), which is the fallback for miscellaneous compliance and regulatory announcements that do not fit other categories. The document length is short (1535 characters), and it is a direct notification letter, not a report or announcement of a report.
2022-09-16 English
General updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which typically covers material events or information that a listed company must disclose to stock exchanges. The content discusses the inclusion of a product in the National List of Essential Medicines and the potential impact on pricing and sales, but it does not contain financial statements, detailed financial results, or management analysis. It is a regulatory announcement about a material event affecting the company, not a full report or financial filing. The document length is short (2225 characters), and it is an announcement rather than a report. Therefore, it fits best under Regulatory Filings (RNS).
2022-09-16 English
The Ministry of Health and Family Welfare, Government of India, has released the revised National List of Essential Medicines (NLEM), 2022. In the coming days, the National Pharmaceutical ....
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which pertains to disclosure of material events by listed companies. It informs about the inclusion of insulin glargine in the National List of Essential Medicines and the expected price revision impact. The document is a regulatory announcement to stock exchanges and does not contain financial statements or detailed financial analysis. It is a short notice informing about a material event affecting the company, fitting the category of Regulatory Filings (RNS). The document length is 2225 characters, which is short and consistent with an announcement rather than a full report.
2022-09-16 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates, citing Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015. It provides details of the lost certificates and requests the information be taken on record. The document is short (1518 characters) and is an announcement of a specific event related to share certificates, not a financial report or detailed filing. It does not contain financial data, management discussion, or regulatory certifications. This fits the category of a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2022-09-14 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges regarding the loss of share certificates, referencing Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements). It contains no financial data, no report content, and is essentially an official notification to take the information on record. The document length is only 1518 characters, indicating it is a brief announcement rather than a full report. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-09-14 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has approved issue of duplicate ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the issue of duplicate share certificates due to lost or misplaced original certificates. It references compliance with SEBI regulations and a SEBI circular. The content is an announcement of a corporate action related to share certificates, not a financial report, management change, or voting result. It is a regulatory compliance notification about share certificate issuance. The document length is short (1619 characters), and it does not contain financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-09-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.